Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides

Add time:07/27/2019    Source:sciencedirect.com

Various diclofenac acid hydrazones and amides were synthesized and evaluated for in vitro and in vivo antimycobacterial activities against Mycobacterium tuberculosis. Preliminary results indicated that most of the compounds demonstrated better in vitro antimycobacterial activity (MIC: 0.0383–7.53 μM) than diclofenac (MIC: 21.10 μM) and ciprofloxacin (MIC: 9.41 μM). Among the synthesized compounds, 1-cyclopropyl-6-fluoro-8-methoxy-7-[[N4-(2-(2-(2,6-dichlorophenylamino)phenyl)acetyl)-3-methyl]-N1-piperazinyl]-4-oxo-1,4-dihydro-3-quinoline carboxylic acid (5d) was found to be the most active compound in vitro with MIC of 0.0383 μM and was more potent than first line antitubercular drug isoniazid (MIC: 0.1822 μM). In the in vivo animal model 5d decreased the bacterial load in lung and spleen tissues with 2.42 − and 3.66 − log 10 protections, respectively, at 25 mg/kg body weight.

We also recommend Trading Suppliers and Manufacturers of 2-METHOXY-QUINOLINE-4-CARBOXYLIC ACID (cas 10222-62-5). Pls Click Website Link as below: cas 10222-62-5 suppliers

Prev:Efficient synthesis of multiply substituted 7H-indeno[2,1-c]quinoline using 7-aminonaphthalene-1,3-disulfonic acid supported on LDHs as catalyst
Next:Salts of phenylacetic acid and 4-hydroxyphenylacetic acid with Cinchona alkaloids: Crystal structures, thermal analysis and FTIR spectroscopy)